3 hours Amylyx Pharmaceuticals (NASDAQ:AMLX) Receives “Buy” Rating from HC WainwrightMarketBeat
HC Wainwright reissued a “buy” rating and set a $8.00 price objective on shares of Amylyx Pharmaceuticals in a research report on Friday.
Nasdaq 100 · Pharmaceuticals · Science
X